Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
On this page, we will discuss an overview of how common are transvaginal mesh complications, statistical evidence of transvaginal mesh complications, ethical considerations of transvaginal mesh, and much more.
Transvaginal mesh has been widely used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).
The transvaginal mesh complications most commonly reported include:
Our experienced team of product liability attorneys at TruLaw estimates settlement values may reach as much as $150,000 to $400,000, depending on the severity of the transvaginal mesh complications.
Use the chat on this page to find out if you qualify to seek compensation in the transvaginal mesh lawsuit today.
Transvaginal mesh has been primarily used to address specific pelvic floor disorders that compromise the quality of life in many women.
This section discusses the two key medical conditions that have historically warranted the use of transvaginal mesh: Pelvic Organ Prolapse (POP) and Stress Urinary Incontinence (SUI).
Pelvic organ prolapse occurs when pelvic organs, such as the bladder, uterus, or rectum, prolapse or bulge into the vaginal canal due to the weakening of the pelvic floor muscles.
Mesh has traditionally been used to treat pelvic organ prolapse and repair pelvic organ prolapse, resulting in pelvic reconstructive surgery.
Here’s how the mesh application generally pertains to different types of prolapses:
As of April 2019, the FDA has banned the use of transvaginal mesh for POP due to safety concerns, as supported by the Cleveland Clinic’s discussion on Surgical Mesh.
Stress urinary incontinence, the involuntary leakage of urine during physical activity or exertion, is the second condition for which mesh procedures have been utilized.
Transvaginal mesh aimed to provide additional support to urethral and bladder neck support structures.
Factors leading to the consideration of mesh for SUI include:
The Mayo Clinic provides insights on the use of surgical mesh in female pelvic reconstructive surgery, including for conditions like stress urinary incontinence.
However, mesh usage for SUI has become less frequent due to associated complications and advancements in other surgical techniques.
Transvaginal mesh complications bring a host of health risks that can significantly impact a patient’s quality of life.
These complications may range from mild to severe and often require medical attention or additional surgical treatment.
Detecting mesh complications is a critical step in ensuring timely treatment and reducing further health risks.
Some indicators of mesh-related complications include:
Certain factors can increase the likelihood of experiencing mesh complications.
These risk factors include:
After undergoing mesh placement, patients may face a variety of complications.
Commonly reported mesh-related complications consist of the following:
Each of these complications can have significant ramifications for the patient’s everyday activities and overall well-being.
For those experiencing severe vaginal mesh complications, surgical treatment may be necessary to remove the mesh and alleviate symptoms.
However, patients should discuss the potential risks and benefits of further surgery with their healthcare provider.
Transvaginal mesh procedures are critical for treating pelvic floor disorders yet require a comprehensive understanding of the surgical techniques and potential postoperative complications.
Transvaginal mesh surgery is commonly employed in pelvic organ prolapse surgery, aiming to provide additional support when pelvic tissues are weakened.
Pelvic reconstructive surgery often involves the insertion of surgical mesh devices to reinforce the vaginal wall.
The standard surgical procedure includes:
Mesh placement must be meticulously performed to reduce the chances of complications.
Surgeons are trained to navigate the complexities of initial surgery and are skilled in determining the appropriate surgical technique for each patient.
Following the surgery, patients are monitored for signs of success and any immediate complications.
Key aspects of postoperative care include:
After pelvic surgery, it is crucial to provide patients with detailed information regarding their recovery timeline and the symptoms they should report if experienced.
Knowledge of potential complications is essential so that they can be addressed promptly if they arise.
Transvaginal mesh complications can be distressing and challenging, requiring surgeons to make careful decisions regarding mesh removal, mesh excision, and potential native tissue repair.
When it comes to managing mesh complications, a multi-faceted approach is often necessary.
Before detailing the potential steps within mesh removal surgery, it is important to understand that each case is unique and requires individual assessment.
Here’s a list of steps that may be involved:
Alternative solutions to transvaginal mesh for POP repair and vaginal prolapse repair offer options for those seeking a different approach or experiencing complications.
These native tissue repair methods use the patient’s tissues to provide support.
Here we have several alternatives:
Considering the minimally invasive nature and reduced risk of complications, many patients and clinicians favor these tissue-based techniques.
However, the choice of procedure will depend on individual patient circumstances, including the severity of prolapse and previous surgical history.
Transvaginal mesh complications have raised significant legal and ethical questions about patient safety and the medical device industry’s responsibilities.
These concerns necessitate a closer examination of regulatory processes and patient advocacy measures.
The Food and Drug Administration (FDA) plays a crucial role in monitoring medical devices, including those for pelvic floor disorders.
Following reports of serious complications related to transvaginal mesh, the agency has implemented stricter controls:
Empowering patients through education about transvaginal mesh is essential for informed consent and self-advocacy.
Here are the key educational and advocacy initiatives that have gained prominence:
Patients may experience symptoms such as pelvic pain, urinary problems, or pain during intercourse indicating bladder mesh issues.
Infections or bleeding are also prominent symptoms associated with bladder mesh complications.
When mesh erosion occurs, non-surgical options like vaginal cream may be employed; however, surgical intervention is often required to remove the exposed mesh.
Each case is evaluated individually to determine the most appropriate course of action.
A bladder sling specifically supports the urethra or bladder neck to manage urinary incontinence.
In contrast, surgical mesh is utilized more broadly for reinforcing weakened pelvic tissues and supporting prolapsed organs.
Pelvic mesh complications may manifest as ongoing pelvic or groin pain, abnormal vaginal discharge, or recurrent urinary tract infections.
The sensation of the mesh being palpable through the vaginal wall may also indicate a complication.
Long-term complications following a bladder sling procedure may include chronic pain, mesh shrinkage, and tissue perforation.
These complications can significantly impact a patient’s quality of life and may require additional surgeries.
Following a hysterectomy involving mesh, complications such as mesh migration, organ perforation, and abnormal bleeding can occur.
Persistent pain and issues with sexual function are also potential long-term complications.
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
You can learn more about the Transvaginal Mesh Lawsuit by visiting any of our pages listed below:
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
AFFF Lawsuit claims are being filed against manufacturers of aqueous film-forming foam (AFFF), commonly used in firefighting.
Claims allege that companies such as 3M, DuPont, and Tyco Fire Products failed to adequately warn users about the potential dangers of AFFF exposure — including increased risks of various cancers and diseases.
Suboxone Tooth Decay Lawsuit claims are being filed against Indivior, the manufacturer of Suboxone, a medication used to treat opioid addiction.
Claims allege that Indivior failed to adequately warn users about the potential dangers of severe tooth decay and dental injuries associated with Suboxone’s sublingual film version.
Social Media Harm Lawsuits are being filed against social media companies for allegedly causing mental health issues in children and teens.
Claims allege that companies like Meta, Google, ByteDance, and Snap designed addictive platforms that led to anxiety, depression, and other mental health issues without adequately warning users or parents.
Transvaginal Mesh Lawsuits are being filed against manufacturers of transvaginal mesh products used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).
Claims allege that companies like Ethicon, C.R. Bard, and Boston Scientific failed to adequately warn about potential dangers — including erosion, pain, and infection.
Bair Hugger Warming Blanket Lawsuits involve claims against 3M — alleging their surgical warming blankets caused severe infections and complications (particularly in hip and knee replacement surgeries).
Plaintiffs claim 3M failed to warn about potential risks — despite knowing about increased risk of deep joint infections since 2011.
Baby Formula NEC Lawsuit claims are being filed against manufacturers of cow’s milk-based baby formula products.
Claims allege that companies like Abbott Laboratories (Similac) and Mead Johnson & Company (Enfamil) failed to warn about the increased risk of necrotizing enterocolitis (NEC) in premature infants.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?